Study: Norouzzadeh 2025, Complementary Therapies in Medicine
Efficacy and safety of Hibiscus sabdariffa in cardiometabolic health: An overview of reviews and updated dose-response meta-analysis
Citation
Norouzzadeh M, Hasan Rashedi M, Azizi MH, Teymoori F et al (2025). Complementary Therapies in Medicine. PubMed id 39870328.
Cards that cite this study (1)
Each card gives its own wording for who was tested, how and what was found.
- Hibiscus (sorrel, zobo, bissap) and blood pressure Tier A thin
B 1,797 people across 26 randomised trials (Iran, Mexico, Egypt, Nigeria and others) (n=1797)
Umbrella review of meta-analyses plus updated dose-response meta-analysis, graded with GRADE and credibility tools.
Hibiscus lowered systolic and diastolic pressure compared with placebo and other teas, dose-dependently, with no significant difference from antihypertensive drugs. The authors rated the credibility of a fall of more than 10 mmHg as moderate. The authors note long-term and therapeutic-dose safety needs monitoring.
As recorded in this card: Norouzzadeh M, Hasan Rashedi M, Azizi MH, Teymoori F et al (2025), Complementary Therapies in Medicine, [review]
This is information, not medical advice. If you are worried, see a doctor or pharmacist. How we grade the evidence. All studies.